|
|
||||||||
Pathogenicity and Medical Microbiology |
Departments of Microbiology/Immunology1, Medicine2 and Pathology3, Northwestern University, Chicago, IL 60611, USA
Author for correspondence: Alan R. Hauser. Tel: +1 312 503 1044. Fax: +1 312 503 1339. e-mail: ahauser{at}northwestern.edu
The type III secretion system of Pseudomonas aeruginosa transports four known effector proteins: ExoS, ExoT, ExoU and ExoY. However, the prevalence of the type III secretion system genes or the effector-encoding genes in clinical and environmental isolates of P. aeruginosa has not been well studied. Southern hybridization analyses and PCR were performed on over 100 P. aeruginosa isolates to determine the distribution of these genes. Clinical isolates were obtained from urine, endotracheal, blood and wound specimens, from the sputum of cystic fibrosis (CF) patients, and from non-hospital environmental sites. The popB gene was used as a marker for the presence of the large chromosomal locus encoding the type III secretion machinery proteins. Each isolate contained the popB gene, indicating that at least a portion of this large chromosomal locus was present in all isolates. Likewise, each isolate contained exoT-like sequences. In contrast, the exoS, exoU and exoY genes were variable traits. Overall, 72% of examined isolates contained the exoS gene, 28% contained the exoU gene, and 89% contained the exoY gene. Interestingly, an inverse correlation was noted between the presence of the exoS and exoU genes in that all isolates except two contained either exoS or exoU but not both. No significant difference in exoS, exoU or exoY prevalence was observed between clinical and environmental isolates or between isolates cultured from different disease sites except for CF respiratory isolates. CF isolates harboured the exoU gene less frequently and the exoS gene more frequently than did isolates from some of the other sites of infection, including the respiratory tract of patients without CF. These results suggest that the P. aeruginosa type III secretion system is present in nearly all clinical and environmental isolates but that individual isolates and populations of isolates from distinct disease sites differ in their effector genotypes. The ubiquity of type III secretion genes in clinical isolates is consistent with an important role for this system in human disease.
Keywords: ExoU, ExoY, ExoS, ExoT, cystic fibrosis
Abbreviations: CF, cystic fibrosis
This article has been cited by other articles:
![]() |
R. D. Stedtfeld, S. W. Baushke, D. M. Tourlousse, S. M. Miller, T. M. Stedtfeld, E. Gulari, J. M. Tiedje, and S. A. Hashsham Development and Experimental Validation of a Predictive Threshold Cycle Equation for Quantification of Virulence and Marker Genes by High-Throughput Nanoliter-Volume PCR on the OpenArray Platform Appl. Envir. Microbiol., June 15, 2008; 74(12): 3831 - 3838. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Angus, A. A. Lee, D. K. Augustin, E. J. Lee, D. J. Evans, and S. M. J. Fleiszig Pseudomonas aeruginosa Induces Membrane Blebs in Epithelial Cells, Which Are Utilized as a Niche for Intracellular Replication and Motility Infect. Immun., May 1, 2008; 76(5): 1992 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cisz, P.-C. Lee, and A. Rietsch ExoS Controls the Cell Contact-Mediated Switch to Effector Secretion in Pseudomonas aeruginosa J. Bacteriol., April 15, 2008; 190(8): 2726 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Soong, D. Parker, M. Magargee, and A. S. Prince The Type III Toxins of Pseudomonas aeruginosa Disrupt Epithelial Barrier Function J. Bacteriol., April 15, 2008; 190(8): 2814 - 2821. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tingpej, L. Smith, B. Rose, H. Zhu, T. Conibear, K. Al Nassafi, J. Manos, M. Elkins, P. Bye, M. Willcox, et al. Phenotypic Characterization of Clonal and Nonclonal Pseudomonas aeruginosa Strains Isolated from Lungs of Adults with Cystic Fibrosis J. Clin. Microbiol., June 1, 2007; 45(6): 1697 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wiehlmann, G. Wagner, N. Cramer, B. Siebert, P. Gudowius, G. Morales, T. Kohler, C. van Delden, C. Weinel, P. Slickers, et al. Population structure of Pseudomonas aeruginosa PNAS, May 8, 2007; 104(19): 8101 - 8106. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Lin, S.-p. Huang, H.-C. Teng, D.-D. Ji, Y.-S. Chen, and Y.-L. Chen Presence of the exoU Gene of Pseudomonas aeruginosa Is Correlated with Cytotoxicity in MDCK Cells but Not with Colonization in BALB/c Mice J. Clin. Microbiol., December 1, 2006; 44(12): 4596 - 4597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bragonzi, L. Wiehlmann, J. Klockgether, N. Cramer, D. Worlitzsch, G. Doring, and B. Tummler Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology, November 1, 2006; 152(Pt 11): 3261 - 3269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Shafikhani and J. Engel Pseudomonas aeruginosa type III-secreted toxin ExoT inhibits host-cell division by targeting cytokinesis at multiple steps PNAS, October 17, 2006; 103(42): 15605 - 15610. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. O'Grady, H. Mulcahy, J. O'Callaghan, C. Adams, and F. O'Gara Pseudomonas aeruginosa Infection of Airway Epithelial Cells Modulates Expression of Kruppel-Like Factors 2 and 6 via RsmA-Mediated Regulation of Type III Exoenzymes S and Y. Infect. Immun., October 1, 2006; 74(10): 5893 - 5902. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Kulasekara, H. D. Kulasekara, M. C. Wolfgang, L. Stevens, D. W. Frank, and S. Lory Acquisition and Evolution of the exoU Locus in Pseudomonas aeruginosa J. Bacteriol., June 1, 2006; 188(11): 4037 - 4050. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ono, K.-S. Park, M. Ueta, T. Iida, and T. Honda Identification of Proteins Secreted via Vibrio parahaemolyticus Type III Secretion System 1 Infect. Immun., February 1, 2006; 74(2): 1032 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Shen, D. Filopon, L. Kuhn, B. Polack, and B. Toussaint PsrA Is a Positive Transcriptional Regulator of the Type III Secretion System in Pseudomonas aeruginosa Infect. Immun., February 1, 2006; 74(2): 1121 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Shaver and A. R. Hauser Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals Microbiology, January 1, 2006; 152(1): 143 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Deng, J. Sun, and J. T. Barbieri Uncoupling Crk Signal Transduction by Pseudomonas Exoenzyme T J. Biol. Chem., October 28, 2005; 280(43): 35953 - 35960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rocha, E. A. Rucks, D. M. Vincent, and J. C. Olson Examination of the Coordinate Effects of Pseudomonas aeruginosa ExoS on Rac1 Infect. Immun., September 1, 2005; 73(9): 5458 - 5467. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Corech, A. Rao, A. Laxova, J. Moss, M. J. Rock, Z. Li, M. R. Kosorok, M. L. Splaingard, P. M. Farrell, and J. T. Barbieri Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis J. Clin. Microbiol., August 1, 2005; 43(8): 3956 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ader, R. Le Berre, K. Faure, P. Gosset, O. Epaulard, B. Toussaint, B. Polack, E. Nowak, N. B. Viget, E. Kipnis, et al. Alveolar Response to Pseudomonas aeruginosa: Role of the Type III Secretion System Infect. Immun., July 1, 2005; 73(7): 4263 - 4271. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Winstanley, S. B Kaye, T. J Neal, H. J Chilton, S. Miksch, C A. Hart, and and the Microbiology Ophthalmic Group Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis J. Med. Microbiol., June 1, 2005; 54(6): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rietsch, I. Vallet-Gely, S. L. Dove, and J. J. Mekalanos ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa PNAS, May 31, 2005; 102(22): 8006 - 8011. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. T. Lee, R. S. Smith, B. Tummler, and S. Lory Activities of Pseudomonas aeruginosa Effectors Secreted by the Type III Secretion System In Vitro and during Infection Infect. Immun., March 1, 2005; 73(3): 1695 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. P. Rabin and A. R. Hauser Functional Regions of the Pseudomonas aeruginosa Cytotoxin ExoU Infect. Immun., January 1, 2005; 73(1): 573 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rucks and J. C. Olson Characterization of an ExoS Type III Translocation-Resistant Cell Line Infect. Immun., January 1, 2005; 73(1): 638 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Shaver and A. R. Hauser Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung Infect. Immun., December 1, 2004; 72(12): 6969 - 6977. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Finnan, J. P. Morrissey, F. O'Gara, and E. F. Boyd Genome Diversity of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients and the Hospital Environment J. Clin. Microbiol., December 1, 2004; 42(12): 5783 - 5792. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Boles, M. Thoendel, and P. K. Singh From the Cover: Self-generated diversity produces "insurance effects" in biofilm communities PNAS, November 23, 2004; 101(47): 16630 - 16635. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain, D. Ramirez, R. Seshadri, J. F. Cullina, C. A. Powers, G. S. Schulert, M. Bar-Meir, C. L. Sullivan, S. A. McColley, and A. R. Hauser Type III Secretion Phenotypes of Pseudomonas aeruginosa Strains Change during Infection of Individuals with Cystic Fibrosis J. Clin. Microbiol., November 1, 2004; 42(11): 5229 - 5237. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Schaber, N. L. Carty, N. A. McDonald, E. D. Graham, R. Cheluvappa, J. A. Griswold, and A. N. Hamood Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa J. Med. Microbiol., September 1, 2004; 53(9): 841 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Goure, A. Pastor, E. Faudry, J. Chabert, A. Dessen, and I. Attree The V Antigen of Pseudomonas aeruginosa Is Required for Assembly of the Functional PopB/PopD Translocation Pore in Host Cell Membranes Infect. Immun., August 1, 2004; 72(8): 4741 - 4750. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Allmond, T. Ajayi, K. Moriyama, J. P. Wiener-Kronish, and T. Sawa V-Antigen Genotype and Phenotype Analyses of Clinical Isolates of Pseudomonas aeruginosa J. Clin. Microbiol., August 1, 2004; 42(8): 3857 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. von Gotz, S. Haussler, D. Jordan, S. S. Saravanamuthu, D. Wehmhoner, A. Strussmann, J. Lauber, I. Attree, J. Buer, B. Tummler, et al. Expression Analysis of a Highly Adherent and Cytotoxic Small Colony Variant of Pseudomonas aeruginosa Isolated from a Lung of a Patient with Cystic Fibrosis J. Bacteriol., June 15, 2004; 186(12): 3837 - 3847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Woestyn, N. Olive, G. Bigaignon, V. Avesani, and M. Delmee Study of Genotypes and virB4 Secretion Gene of Bartonella henselae Strains from Patients with Clinically Defined Cat Scratch Disease J. Clin. Microbiol., April 1, 2004; 42(4): 1420 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Yu, P. S. S. Rao, H. C. Lee, S. Vilches, S. Merino, J. M. Tomas, and K. Y. Leung A Type III Secretion System Is Required for Aeromonas hydrophila AH-1 Pathogenesis Infect. Immun., March 1, 2004; 72(3): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Garrity-Ryan, S. Shafikhani, P. Balachandran, L. Nguyen, J. Oza, T. Jakobsen, J. Sargent, X. Fang, S. Cordwell, M. A. Matthay, et al. The ADP Ribosyltransferase Domain of Pseudomonas aeruginosa ExoT Contributes to Its Biological Activities Infect. Immun., January 1, 2004; 72(1): 546 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lanotte, S. Watt, L. Mereghetti, N. Dartiguelongue, A. Rastegar-Lari, A. Goudeau, and R. Quentin Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins J. Med. Microbiol., January 1, 2004; 53(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Phillips, D. A. Six, E. A. Dennis, and P. Ghosh In Vivo Phospholipase Activity of the Pseudomonas aeruginosa Cytotoxin ExoU and Protection of Mammalian Cells with Phospholipase A2 Inhibitors J. Biol. Chem., October 17, 2003; 278(42): 41326 - 41332. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ajayi, L. R. Allmond, T. Sawa, and J. P. Wiener-Kronish Single-Nucleotide-Polymorphism Mapping of the Pseudomonas aeruginosa Type III Secretion Toxins for Development of a Diagnostic Multiplex PCR System J. Clin. Microbiol., August 1, 2003; 41(8): 3526 - 3531. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Wolfgang, B. R. Kulasekara, X. Liang, D. Boyd, K. Wu, Q. Yang, C. G. Miyada, and S. Lory Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa PNAS, July 8, 2003; 100(14): 8484 - 8489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. P. Rabin and A. R. Hauser Pseudomonas aeruginosa ExoU, a Toxin Transported by the Type III Secretion System, Kills Saccharomyces cerevisiae Infect. Immun., July 1, 2003; 71(7): 4144 - 4150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyata, M. Casey, D. W. Frank, F. M. Ausubel, and E. Drenkard Use of the Galleria mellonella Caterpillar as a Model Host To Study the Role of the Type III Secretion System in Pseudomonas aeruginosa Pathogenesis Infect. Immun., May 1, 2003; 71(5): 2404 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Faure, D. Shimabukuro, T. Ajayi, L. R. Allmond, T. Sawa, and J. P. Wiener-Kronish O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa J. Clin. Microbiol., May 1, 2003; 41(5): 2158 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rucks, J. E. Fraylick, L. M. Brandt, T. S. Vincent, and J. C. Olson Cell line differences in bacterially translocated ExoS ADP-ribosyltransferase substrate specificity Microbiology, February 1, 2003; 149(2): 319 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jacob, R. J. Lee, J. N. Engel, and T. E. Machen Modulation of Cytosolic Ca2+ Concentration in Airway Epithelial Cells by Pseudomonas aeruginosa Infect. Immun., November 1, 2002; 70(11): 6399 - 6408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pukatzki, R. H. Kessin, and J. J. Mekalanos The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum PNAS, February 20, 2002; (2002) 52704399. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pukatzki, R. H. Kessin, and J. J. Mekalanos The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum PNAS, March 5, 2002; 99(5): 3159 - 3164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |